Figure 4

Overall survival according to RVD at baseline. Kaplan–Meier overall survival estimates for patients still under study at 200 days (landmark analysis) with RVD (solid line) vs. patients without RVD (dashed line).
Overall survival according to RVD at baseline. Kaplan–Meier overall survival estimates for patients still under study at 200 days (landmark analysis) with RVD (solid line) vs. patients without RVD (dashed line).